Medications in Bronchospasm and Asthma among the Critically Ill Patients: A Drug Utilization Study from Southern India
Lisha Jenny John, Jenny Ann John, Padmini Devi, Mohamed Arifulla, Shoba Guido
Abstract
Open-access reader
Lisha Jenny John, Jenny Ann John, Padmini Devi, Mohamed Arifulla, Shoba Guido
Abstract
Open-access reader
Objective: Critically ill patients are prone for altered reactivity of the airway and drug therapy has pivotal role in the management of bronchospasm. The objective of the study was to evaluate the prescribing patterns and adverse effects of therapeutic agents for bronchospasm and asthma in the medical ICU.Methods: A prospective observational study was carried out among inpatients of the medical ICU receiving drugs for bronchospasm and asthma.Results: 220 patients received drugs for bronchospasm and asthma. Male preponderance was noticed (60.5%). Salbutamol (R03AC02) 92.7% was the most common bronchodilator prescribed. Ipratropium plus salbutamol (R03AK04) 55.5% was most frequently used bronchodilator combination. All bronchodilators were administered by inhalational route (nebulization) except methylxanthines Conclusion: Utilization patterns of drugs for bronchospasm and asthma were in concordance with treatment guidelines.Key words: Bronchospasm; Asthma; Southern IndiaDOI: http://dx.doi.org/10.3126/nje.v1i2.5136 Nepal Journal of Epidemiology 2011;1 (2):57-59
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: Critically ill patients are prone for altered reactivity of the airway and drug therapy has pivotal role in the management of bronchospasm. The objective of the study was to evaluate the prescribing patterns and adverse effects of therapeutic agents for bronchospasm and asthma in the medical ICU.Methods: A prospective observational study was carried out among inpatients of the medical ICU receiving drugs for bronchospasm and asthma.Results: 220 patients received drugs for bronchospasm and asthma. Male preponderance was noticed (60.5%). Salbutamol (R03AC02) 92.7% was the most common bronchodilator prescribed. Ipratropium plus salbutamol (R03AK04) 55.5% was most frequently used bronchodilator combination. All bronchodilators were administered by inhalational route (nebulization) except methylxanthines Conclusion: Utilization patterns of drugs for bronchospasm and asthma were in concordance with treatment guidelines.Key words: Bronchospasm; Asthma; Southern IndiaDOI: http://dx.doi.org/10.3126/nje.v1i2.5136 Nepal Journal of Epidemiology 2011;1 (2):57-59
Key concepts: Bronchospasm, Medicine, Salbutamol, Asthma, Bronchodilator, Intensive care medicine, Anesthesia, Drug